![Jeegar Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeegar Patel
Directeur Technique/Scientifique/R&D chez
EVOMMUNE, INC.
Fortune : 616 696 $ au 30/06/2026
Profil
Jeegar Patel is currently Chief Scientific Officer at Evommune, Inc. since 2022.
Formerly, Dr. Patel was Senior VP-Research & Nonclinical Development at Kadmon Holdings, Inc. Education includes an undergraduate degree from the University of the Sciences in Philadelphia and a doctorate from Drexel University College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOMMUNE, INC. 0,13% | 22/06/2026 | 46 403 ( 0,13% ) | 616 696 $ | 30/06/2026 |
Postes actifs de Jeegar Patel
| Sociétés | Poste | Début |
|---|---|---|
| EVOMMUNE, INC. | Directeur Technique/Scientifique/R&D | 03/10/2022 |
Anciens postes connus de Jeegar Patel
| Sociétés | Poste | Fin |
|---|---|---|
| KADMON HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Jeegar Patel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
University of the Sciences in Philadelphia
 University of the Sciences in Philadelphia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Choisissez Zonebourse 
